Literature DB >> 28747841

Onychomadesis: A rare adverse effect in early-period valproic acid therapy.

Serhat Güler1, İlhan Işık1, Akın İşcan1.   

Abstract

Valproic acid is an effective, frequently used anticonvulsant drug. Typical adverse effects include weight gain, hair loss, and nausea. Hyperpigmentation, onycholysis, and onychomadesis are nail changes that can be seen after valproic acid use. Changes occur at the distal and proximal portions of the nail bed in onycholysis and onychomadesis, respectively. Onychomadesis is a very rare disease of childhood with the exception of systemic and genetic diseases. Here, we present a child aged 23 months, the youngest and the earliest isolated patient with onychomadesis, which occurred after valproic acid treatment and worried the family but resolved spontaneously. The improvement of this very rare adverse effect of antiepileptic drugs after cessation of valproic acid without treatment is emphasized.

Entities:  

Keywords:  Adverse effect; epilepsy; onychomadesis; valproic acid

Year:  2017        PMID: 28747841      PMCID: PMC5509130          DOI: 10.5152/TurkPediatriArs.2015.2630

Source DB:  PubMed          Journal:  Turk Pediatri Ars


  3 in total

1.  Generalized onycholysis associated with sodium valproate therapy.

Authors:  V Grech; C Vella
Journal:  Eur Neurol       Date:  1999-07       Impact factor: 1.710

Review 2.  Drug reactions affecting the nail unit: diagnosis and management.

Authors:  Bianca Maria Piraccini; Matilde Iorizzo
Journal:  Dermatol Clin       Date:  2007-04       Impact factor: 3.478

3.  Onychomadesis: a rare side-effect of valproic acid medication?

Authors:  Andrea Poretti; Ulrich Lips; Marco Belvedere; Bernhard Schmitt
Journal:  Pediatr Dermatol       Date:  2009 Nov-Dec       Impact factor: 1.588

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.